The EMPOWER-1 study sample comprises patients diagnosed with specific physical and mental illnesses like cancer or depression, or National Health Service (NHS) patients associated with participating study sites in the UK. Participants were primarily from the three main ethnic groups in the UK; namely White (Caucasian), African-Caribbean (Black), and South Asian (Asian) populations on a 1:1:1 ratio. All participants were registered with the NHS for care, have a lack of capacity without an illness under investigation, and a lack of capacity without advice from a personal consultee.
Study design
Cohort - clinical
Number of participants at first data collection
200,000 (participants)
Recruitment is ongoing
Age at first data collection
≥ 6 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2021
Primary Institutions
Future Genetics Ltd.
Profile paper DOI
Not available
Funders
Future Genetics Ltd.
Ongoing?
Yes
Data types collected
Engagement
Keywords